137 related articles for article (PubMed ID: 30284131)
1. Survival Impact of Total Resected Lymph Nodes in Esophageal Cancer Patients With and Without Neoadjuvant Chemoradiation.
Ho HJ; Chen HS; Hung WH; Hsu PK; Wu SC; Chen HC; Wang BY
Ann Surg Oncol; 2018 Dec; 25(13):3820-3832. PubMed ID: 30284131
[TBL] [Abstract][Full Text] [Related]
2. Comparative Quantitative Lymph Node Assessment in Localized Esophageal Cancer Patients After R0 Resection With and Without Neoadjuvant Chemoradiation Therapy.
Giugliano DN; Berger AC; Pucci MJ; Rosato EL; Evans NR; Meidl H; Lamb C; Levine D; Palazzo F
J Gastrointest Surg; 2017 Sep; 21(9):1377-1384. PubMed ID: 28664255
[TBL] [Abstract][Full Text] [Related]
3. Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients.
Fujiwara Y; Yoshikawa R; Kamikonya N; Nakayama T; Kitani K; Tsujie M; Yukawa M; Inoue M; Yamamura T
Oncol Rep; 2012 Aug; 28(2):446-52. PubMed ID: 22664791
[TBL] [Abstract][Full Text] [Related]
4. Survival benefits of adjuvant chemotherapy for patients with residual pathologic disease after neoadjuvant chemotherapy and surgery for locally advanced esophageal squamous cell carcinoma.
Lu H; Liu JF; Rong Y; Liu XB; Wang Y
J Gastrointest Surg; 2024 Jun; 28(6):867-869. PubMed ID: 38570232
[TBL] [Abstract][Full Text] [Related]
5. Supracarinal lymph node positivity in esophageal squamous cell carcinoma (ESCC) and factors predicting metastasis in supracarinal compartment nodes: Should a total mediastinal node dissection be the standard of care?
Jain AR; Sadhwani MA; Vyas RD; Pandya SJ; Sharma MR; Warikoo V; Puj KS; Salunke AA
Indian J Cancer; 2023; 60(2):185-190. PubMed ID: 37530239
[TBL] [Abstract][Full Text] [Related]
6. Identification of Optimal Parameters for Assessing Lymph Node Status of Patients with Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy.
Huang X; Jiang D; Jian Z; Zeng Z; Zhang S; Fan H; Sun T; Tang H; Hou Y; Tan L
Ann Surg Oncol; 2024 Feb; 31(2):883-891. PubMed ID: 38038788
[TBL] [Abstract][Full Text] [Related]
7. Nodal Yield <15 Is Associated With Reduced Survival in Esophagectomy and Is a Quality Metric.
Bolger JC; Castro PP; Marwah A; Tavakoli I; Espin-Garcia O; Darling GE; Yeung JC
Ann Thorac Surg; 2023 Jul; 116(1):130-136. PubMed ID: 36918078
[TBL] [Abstract][Full Text] [Related]
8. Lymph Node Harvest During Esophagectomy Is Not Influenced by Use of Neoadjuvant Therapy or Clinical Disease Stage.
Luna RA; Dolan JP; Diggs BS; Bronson NW; Sheppard BC; Schipper PH; Tieu BH; Feeney BT; Gatter KM; Vaccaro GM; Thomas CR; Hunter JG
J Gastrointest Surg; 2015 Jul; 19(7):1201-7. PubMed ID: 25910454
[TBL] [Abstract][Full Text] [Related]
9. Increased resected lymph node stations improved survival of esophageal squamous cell carcinoma.
Lu RD; Wei ZD; Liu YX; Tian D; Zhang HL; Shang QX; Hu WP; Yang L; Yang YS; Chen LQ
BMC Cancer; 2024 Feb; 24(1):177. PubMed ID: 38317075
[TBL] [Abstract][Full Text] [Related]
10. Value of Lymphadenectomy in Patients Receiving Neoadjuvant Therapy for Esophageal Adenocarcinoma.
Raja S; Rice TW; Murthy SC; Ahmad U; Semple ME; Blackstone EH; Ishwaran H;
Ann Surg; 2021 Oct; 274(4):e320-e327. PubMed ID: 31850981
[TBL] [Abstract][Full Text] [Related]
11. Patterns and Influence of Lymph Nodal Metastases After Neoadjuvant Chemotherapy and Surgery for Thoracic Esophageal Squamous Cell Carcinoma.
Sun HB; Jiang D; Liu XB; Xing WQ; Chen PN; Feng SK; Yan S
Ann Surg Oncol; 2023 Aug; 30(8):5205-5212. PubMed ID: 37162643
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of diffusion-weighted magnetic resonance imaging in assessing lymph node metastasis of esophageal cancer compared with PET.
Shuto K; Kono T; Shiratori T; Akutsu Y; Uesato M; Mori M; Narushima K; Imanishi S; Nabeya Y; Yanagawa N; Okazumi S; Koda K; Matsubara H
Esophagus; 2020 Jul; 17(3):239-249. PubMed ID: 31820208
[TBL] [Abstract][Full Text] [Related]
13. Impact of Metastatic Lymph Nodes on Survival of Patients with pN1-Category Esophageal Squamous Cell Carcinoma: A Long-Term Survival Analysis.
Li K; Du K; Li C; He W; Lu S; Liu K; Wang C; Nie X; Han Y; Huang Y; Wang Q; Peng L; Leng X
Ann Surg Oncol; 2024 Jun; 31(6):3794-3802. PubMed ID: 38372864
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of Radiation-Associated Esophageal Squamous Cell Carcinoma: The MSKCC Experience.
Nobel TB; Barbetta A; Hsu M; Tan KS; Pinchinat T; Schlottmann F; Bains MS; Ku GY; Wu AJ; Patti MG; Jones DR; Molena D
J Gastrointest Surg; 2019 Jan; 23(1):11-22. PubMed ID: 30215197
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of positive lymph node regression grade to neoadjuvant chemoradiation for esophageal squamous cell carcinoma.
Yehan Z; Ying L; Peng G; Zongyao H; Chengmin Z; Hong Y; Sheng Q; Jie Z; Yi W; Xuefeng L; Wenwu H; Qifeng W; Yang L
J Surg Oncol; 2024 Mar; 129(4):708-717. PubMed ID: 38124398
[TBL] [Abstract][Full Text] [Related]
16. Comparison of indocyanine green-near-infrared fluorescence guided and traditional mediastinal lymphadenectomy during radical esophagectomy: A randomized controlled trial.
Du J; Zeng T; Zhang S; Chen M; Huang G; Xu C; Xu G; Ni C; Hong R; Zheng W; Chen C; Zheng B
Surgery; 2024 Feb; 175(2):347-352. PubMed ID: 38012899
[TBL] [Abstract][Full Text] [Related]
17. Pathologic Complete Response Is an Independent Predictor of Improved Survival Following Neoadjuvant Chemoradiation for Esophageal Adenocarcinoma.
Alnaji RM; Du W; Gabriel E; Singla S; Attwood K; Nava H; Malhotra U; Hochwald SN; Kukar M
J Gastrointest Surg; 2016 Sep; 20(9):1541-6. PubMed ID: 27260525
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Pathologic Supraclavicular Lymph Node Metastases in Esophageal Squamous Cell Carcinoma Treated by Esophagectomy with Three-Field Lymph Node Dissection.
Park SY; Lee J; Jeon YJ; Cho JH; Kim HK; Choi YS; Zo JI; Shim YM
Ann Surg Oncol; 2024 May; 31(5):3399-3408. PubMed ID: 38082171
[TBL] [Abstract][Full Text] [Related]
19. Completely Resectable (cT1-2) Esophageal Squamous Cell Carcinoma with Minimal Lymph Node Involvement (cN1): Is Neoadjuvant Chemoradiation Therapy the Only Viable Treatment Option?
Yang YH; Park BJ; Kim HE; Kim H; Kim DJ
Ann Surg Oncol; 2024 Apr; 31(4):2490-2498. PubMed ID: 38153644
[TBL] [Abstract][Full Text] [Related]
20. A Comparison of Clinicopathologic Outcomes and Patterns of Lymphatic Spread Across Neoadjuvant Chemotherapy, Neoadjuvant Chemoradiotherapy, and Neoadjuvant Immunochemotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma.
Tian Y; Shi Z; Wang C; Ke S; Qiu H; Zhao W; Wu Y; Chen J; Zhang Y; Chen Y
Ann Surg Oncol; 2024 Feb; 31(2):860-871. PubMed ID: 37947979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
